|
MechanismNMDA receptor antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Slyptai (Shanghai) Biomedical Technology Co., Ltd.
0 Patents (Medical) associated with Slyptai (Shanghai) Biomedical Technology Co., Ltd.
100 Deals associated with Slyptai (Shanghai) Biomedical Technology Co., Ltd.
100 Translational Medicine associated with Slyptai (Shanghai) Biomedical Technology Co., Ltd.